GlaxoSmithKline in Talks with Human Genome Sciences -Sources
Human Genome had previously rejected GSK's $13/share bid. There was heavy volume in the October 16 HGSI call on Friday just before the close. HGSI closed at $13.58 on Friday.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.